glaucoma

Displaying 1 - 3 of 3

NEI grants help bolster glaucoma research efforts

Two Vanderbilt Eye Institute (VEI) researchers were recently awarded National Eye Institute (NEI) Audacious Goals Initiative (AGI) for Regenerative Medicine grants for $6.8 million over five years to develop new treatments for optic neuropathies and glaucoma, the leading cause of irreversible blindness.

Related Categories: 
glaucoma national eye institute Vanderbilt Eye Institute

Novel methods to treat glaucoma

Glaucoma is characterized by degeneration of retinal ganglion cells, leading to irreversible vision loss. Currently, the only treatable glaucoma risk factor is increased intraocular pressure.

Related Categories: 
Research glaucoma rebecca sappington

Glaucoma study finds brain fights to preserve vision

A team of researchers, led by David Calkins, PhD, vice chair and director of Research at the Vanderbilt Eye Institute, has made a breakthrough discovery in the field of glaucoma showing new hopes for treatments to preserve vision.

Related Categories: 
glaucoma David Calkins Vanderbilt Eye Institute neurodegenerative disorders Wendi Lambert Michael Risner Melissa Cooper Silvia Pasini